Boys and Girls Club of Puerto Rico

Financing for several locations of the Boys and Girls Club of Puerto Rico, providing after school programs and services to children and youth ages 6 to 18.

Investment

  • NMTC Amount: $8,000,000
  • Total Project Cost: $8,000,000

IMPACT

  • 38 FTE jobs
  • Services over 15,000 children annually.

Investor

Voices from the Community

Projects supported by this program obtain flexible capital to create more job opportunities for low-income people. This is essentially important to fund more projects that will get our people out of poverty and provide them with a high-quality job and a bright future for them and their families.

-Giovanna Piovanetti, Executive President, Corporacion para el Financiamiento Empresarial del Comercio y las Comunidades, San Juan, Puerto Rico

Project Description

Investor: Capital One, N. A. For more than 50 years, the Boys & Girls Club of Puerto Rico (BGCPR) has provided after school programs and services to children and youth ages 6 to 18. It offers participants a safe and creative place to develop and achieve their academic, personal and professional goals. The Project provided working and operational capital for the purpose of stabilization and expansion of the Boys & Girls Club of Puerto Rico’s clubs and activities in various locations on the island. Hurricanes Irma and María left the Puerto Rico community more vulnerable than ever making the services provided by BGCPR to the more than 15,000 children and youth annually indispensable and necessary.

Other Puerto Rico Projects

New multi-functional facility houses Puerto Rico’s first charter school in one of the island’s most economically underserved and isolated communities
A 246-bed Acute Care Hospital located in Caguas, Puerto Rico whose primary function is to provide inpatient diagnostic and therapeutic services for a variety of medical conditions, both surgical and

Boys and Girls Club with after-school programs and other youth enrichment.

NMTC financing supported the rehabilitation of a former warehouse into a 40,000 square foot pharmaceutical manufacturing plant where it produces Alinia, a prescription drug that treats illnesses caused by Crypotsporidium